WG4 webinar (April 16th 2024)

New Research Highlight from EU-METAHEART consortium “Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage” by Panagiota-Efstathia Nicolau, Ioanna Andreadou and collaborators. The study...

A recent publication co-authored by core members of the EU-METAHEART COST Action focuses on the multifaceted mechanisms driving cardiac amyloidosis and explores potential therapeutic avenues. The paper, entitled “Mechanisms of...

As WG2 leaders, Luca Liberale, Bruno Podesser, and Gerd Heusch presented the scope and objectives of the METAHEART COST action, focusing on WG2 activities. The update covered recent group developments...

Dear colleagues, For a recently approved grant, I am currently looking for a post-doc with expertise on data science in exercise/muscle physiology, with a specific focus on Long COVID. The postdoc...

The MDC offers a highly vibrant scientific environment, with state-of-the-art infrastructure for immunological platforms such as flow cytometry, single-cell transcriptomics, spatial transcriptomics, metabolomics and proteomics, imaging, and in vivo work....

The 1st paper of the EU-METAHEART COST Action was published in European Heart Journal: https://doi.org/10.1093/eurheartj/ehae457 Take a look!